Please Note: This trial is no longer enrolling new participants
A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M17D1 in Subjects with HER2 Expressing or HER2 Mutant Advanced or Metastatic Solid Tumors
| Protocol No. | CTO-BL-M17D1-ST-101 | Scope | National |
|---|---|---|---|
| Principal Investigator | Rohan Maniar | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase I |
